Pharmacokinetics, Mass Balance, and Biotransformation of a Novel Dual-Target Neuroprotectant [14C]Loberamisal (Y-3) in Humans: Clues from Rat Studies, Mechanistic Roles of UDP-Glucuronosyltransferase and Gut Microbiota
Drug Metabolism and Disposition · 2026-11 · 100441
DOI: 10.1016/j.dmd.2026.100441 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-11. Verfasst von Jian Ren und 9 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ren, J., Chen, T., Xue, J., Yan, S., Hua, Y., Huang, X., Liu, H., Diao, X., Shao, F., & Ding, L. (2026). Pharmacokinetics, Mass Balance, and Biotransformation of a Novel Dual-Target Neuroprotectant [14C]Loberamisal (Y-3) in Humans: Clues from Rat Studies, Mechanistic Roles of UDP-Glucuronosyltransferase and Gut Microbiota. Drug Metabolism and Disposition, 100441. https://doi.org/10.1016/j.dmd.2026.100441
Vancouver
Ren J, Chen T, Xue J, Yan S, Hua Y, Huang X, et al. Pharmacokinetics, Mass Balance, and Biotransformation of a Novel Dual-Target Neuroprotectant [14C]Loberamisal (Y-3) in Humans: Clues from Rat Studies, Mechanistic Roles of UDP-Glucuronosyltransferase and Gut Microbiota. Drug Metabolism and Disposition. 2026:100441. doi:10.1016/j.dmd.2026.100441
BibTeX
@article{Ren2026,
author = {Ren, Jian and Chen, Taoyu and Xue, Jingzhi and Yan, Shu and Hua, Yao and Huang, Xintong and Liu, Haonan and Diao, Xingxing and Shao, Feng and Ding, Li},
title = {Pharmacokinetics, Mass Balance, and Biotransformation of a Novel Dual-Target Neuroprotectant [14C]Loberamisal (Y-3) in Humans: Clues from Rat Studies, Mechanistic Roles of UDP-Glucuronosyltransferase and Gut Microbiota},
journal = {Drug Metabolism and Disposition},
year = {2026},
pages = {100441},
doi = {10.1016/j.dmd.2026.100441}
}
EUVIMED